- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | Tivic Health Systems: Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10 | 511 | ACCESS Newswire | Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure. FREMONT, CA / ACCESS... ► Artikel lesen | |
| 09.02. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.01. | Tivic Health Systems: Tivic, BARDA Discuss Entolimod for Acute Radiation Syndrome at TechWatch Meeting | 372 | ACCESS Newswire | January 26 Presentation highlighted Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposureBARDA has requested a follow-up meeting... ► Artikel lesen | |
| 26.01. | DealFlow Events: Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod to Commercialization at DealFlow Discovery Conference | 262 | ACCESS Newswire | CEO Presentation to Include Updates and Further Information on the Following Topics:Entolimod Cell Line Verification Success;200x Manufacturing Scale-Up with Reproducible Quality;BARDA TechWatch Engagement... ► Artikel lesen | |
| 21.01. | Tivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference | 839 | ACCESS Newswire | Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod FREMONT, CA / ACCESS Newswire / January 20, 2026 / Tivic Health Systems, Inc. (NASDAQ:TIVC)... ► Artikel lesen | |
| 20.01. | Tivic Health Systems, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 12.01. | Tivic Health Systems: Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod And Achieves Reproducible Yields, Potency and Purity | 446 | ACCESS Newswire | Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing... ► Artikel lesen | |
| TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 08.01. | Tivic Health Systems: Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines | 267 | ACCESS Newswire | Conference Call to be Hosted on Monday, January 12 at 1:30 PM PT/4:30 PM ET FREMONT, CA / ACCESS Newswire / January 8, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics... ► Artikel lesen | |
| 11.12.25 | Tivic Acquires Scorpius Holdings Manufacturing Assets And Secures More Than $90 Million Financing | 6 | pulse2.com | ||
| 11.12.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 11.12.25 | Tivic Health übernimmt Produktionsanlagen und gründet CDMO-Tochtergesellschaft | 3 | Investing.com Deutsch | ||
| 11.12.25 | Tivic Health acquires manufacturing assets, launches CDMO subsidiary | 7 | Investing.com | ||
| 11.12.25 | Tivic Health Systems: Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package | 402 | ACCESS Newswire | Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity BioworksFinancing led by 3i, LP includes... ► Artikel lesen | |
| 18.11.25 | Tivic Health Systems: Tivic Secures Barda Meeting for Entolimod for Acute Radiation Syndrome | 410 | ACCESS Newswire | Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company... ► Artikel lesen | |
| 14.11.25 | Earnings Call: Strategiewechsel bei Tivic Health Systems belastet Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
| 14.11.25 | Tivic Health Systems GAAP EPS of -$1.97, revenue of $0.15M | 4 | Seeking Alpha | ||
| 14.11.25 | Tivic Health Systems: Tivic Reports Third Quarter 2025 Financial Results | 2.080 | ACCESS Newswire | Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics... ► Artikel lesen | |
| 13.11.25 | Tivic Health erzielt Fortschritte bei der Optimierung der Nervenstimulation | 1 | Investing.com Deutsch | ||
| 13.11.25 | Tivic Health optimizes nerve stimulation parameters in new study | 3 | Investing.com | ||
| 13.11.25 | Tivic Health Systems: Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation | 318 | ACCESS Newswire | The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc.... ► Artikel lesen |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,370 | -2,41 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -1,05 % | Fresenius: Weiteres Wachstum in Sicht - Aktie bärenstark | Am kommenden Mittwoch (25. Februar) wird der Gesundheitskonzern Fresenius die Zahlen für das vergangene vierte Quartal respektive Gesamtjahr 2025 vorlegen. Der Markt rechnet sowohl umsatz- als auch... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,840 | +1,58 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,800 | -5,43 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| GERRESHEIMER | 16,120 | +2,68 % | Aktien Frankfurt: Neue US-Zollunsicherheit sorgt für Verluste | FRANKFURT (dpa-AFX) - Der Dax ist am Montag nach einem versöhnlichen Wochenausklang etwas unter Druck geraten. Die Verluste hielten sich aber angesichts der Unsicherheit über neue US-Zölle in Grenzen.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,110 | -0,40 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen TIVIC HEALTH SYSTEMS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,829 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIVIC HEALTH SYSTEMS INC finden Sie auf Wallstreet Online.